These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24657655)
1. RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion. Boregowda RK; Olabisi OO; Abushahba W; Jeong BS; Haenssen KK; Chen W; Chekmareva M; Lasfar A; Foran DJ; Goydos JS; Cohen-Solal KA Cancer Lett; 2014 Jun; 348(1-2):61-70. PubMed ID: 24657655 [TBL] [Abstract][Full Text] [Related]
2. BEL β-Trefoil Reduces the Migration Ability of RUNX2 Expressing Melanoma Cells in Xenotransplanted Zebrafish. Valenti MT; Marchetto G; Perduca M; Tiso N; Mottes M; Dalle Carbonare L Molecules; 2020 Mar; 25(6):. PubMed ID: 32168858 [TBL] [Abstract][Full Text] [Related]
3. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma. Guo H; Cheng Y; Martinka M; McElwee K Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521 [TBL] [Abstract][Full Text] [Related]
4. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb. Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503 [TBL] [Abstract][Full Text] [Related]
5. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB. Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220 [TBL] [Abstract][Full Text] [Related]
6. Runx2 stimulates neoangiogenesis through the Runt domain in melanoma. Cecconi D; Brandi J; Manfredi M; Serena M; Dalle Carbonare L; Deiana M; Cheri S; Parolini F; Gandini A; Marchetto G; Innamorati G; Avanzi F; Antoniazzi F; Marengo E; Tiso N; Mottes M; Zipeto D; Valenti MT Sci Rep; 2019 May; 9(1):8052. PubMed ID: 31142788 [TBL] [Abstract][Full Text] [Related]
7. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance. Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041 [TBL] [Abstract][Full Text] [Related]
8. Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity. Underwood KF; D'Souza DR; Mochin-Peters M; Pierce AD; Kommineni S; Choe M; Bennett J; Gnatt A; Habtemariam B; MacKerell AD; Passaniti A J Bone Miner Res; 2012 Apr; 27(4):913-25. PubMed ID: 22189971 [TBL] [Abstract][Full Text] [Related]
9. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104 [TBL] [Abstract][Full Text] [Related]
10. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells. Koch A; Lang SA; Wild PJ; Gantner S; Mahli A; Spanier G; Berneburg M; Müller M; Bosserhoff AK; Hellerbrand C Oncotarget; 2015 Oct; 6(32):32748-60. PubMed ID: 26293674 [TBL] [Abstract][Full Text] [Related]
11. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor. Martin del Campo SE; Latchana N; Levine KM; Grignol VP; Fairchild ET; Jaime-Ramirez AC; Dao TV; Karpa VI; Carson M; Ganju A; Chan AN; Carson WE PLoS One; 2015; 10(1):e0115919. PubMed ID: 25587717 [TBL] [Abstract][Full Text] [Related]
12. Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma. Riminucci M; Corsi A; Peris K; Fisher LW; Chimenti S; Bianco P Calcif Tissue Int; 2003 Sep; 73(3):281-9. PubMed ID: 14667142 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma. Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053 [TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential cation 3 channel regulates melanoma proliferation and migration. Oda K; Umemura M; Nakakaji R; Tanaka R; Sato I; Nagasako A; Oyamada C; Baljinnyam E; Katsumata M; Xie LH; Narikawa M; Yamaguchi Y; Akimoto T; Ohtake M; Fujita T; Yokoyama U; Iwatsubo K; Aihara M; Ishikawa Y J Physiol Sci; 2017 Jul; 67(4):497-505. PubMed ID: 27613608 [TBL] [Abstract][Full Text] [Related]
16. The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma. Iizuka S; Abdullah C; Buschman MD; Diaz B; Courtneidge SA Oncotarget; 2016 Nov; 7(48):78473-78486. PubMed ID: 27802184 [TBL] [Abstract][Full Text] [Related]
17. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression. Wang Q; Yu W; Huang T; Zhu Y; Huang C Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365 [TBL] [Abstract][Full Text] [Related]
18. Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells. Mizuhashi S; Fukushima S; Ishibashi T; Kuriyama H; Kimura T; Kanemaru H; Kajihara I; Makino K; Miyashita A; Aoi J; Kita K; Ihn H J Dermatol Sci; 2021 Apr; 102(1):16-24. PubMed ID: 33583643 [TBL] [Abstract][Full Text] [Related]
19. CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration. Braig S; Wallner S; Junglas B; Fuchshofer R; Bosserhoff AK Br J Cancer; 2011 Jul; 105(2):231-8. PubMed ID: 21673687 [TBL] [Abstract][Full Text] [Related]